The purpose of this study is to evaluate the effects of Amlodipine, a calcium channel blocker, on mortality and morbidity in patients with severe congestive heart failure. Other endpoints include quality of life score, alteration of NYHA functional status, and neurohormones.
Showing the most recent 10 out of 128 publications